Search Results 301-310 of 24221 for In situ

  1. Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma - Mayo Clinic

    ... in situ [Stage 0], curatively treated localized prostate cancer, and cervical carcinoma in situ on biopsy or a squamous intraepithelial lesion on PAP smear.

  2. CLEOPATTRA: A Research Study To Look At The Effects Of Treatment With A Medicine Called Coramitug (NNC6019-0001) In People With Heart Failure Due To Transthyretin Amyloid (ATTR) Amyloidosis - Mayo Clinic

    This study will find out if a new medicine called NNC6019-0001 can help reduce the risk of heart-related death and illness in participants with a condition ...

  3. A Study of Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients with Previously Treated Multiple Myeloma or Plasma Cell Leukemia - Mayo Clinic

    A Study of Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients with Previously Treated Multiple Myeloma or Plasma Cell Leukemia ... in situ ( ...

  4. Fibromyalgia Clinical Trials - Mayo Clinic Research

    The purpose of this study is to build the knowledge of in-situ clinical experiences essential to developing decision aids for patients considering treatment ...

  5. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    Carcinoma in situ of the cervix;; Carcinoma in situ of the breast;; Incidental histologic finding of prostate cancer (T1a or T1b using the TNM [tumor, nodes ...

  6. Robotic surgery - Doctors & Departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. ... situ, Lobular ...

  7. A Study Comparing the Outcomes of Observation versus Immediate Surgery for Low Risk Bladder Cancer - Mayo Clinic

    Noninvasive appearance (Ta). No history of carcinoma in situ (CIS) or lesions concerning for CIS; Negative urine cytology (atypical or suspicious for low ...

  8. Genomics of Lung Cancer Progression Varies Widely Among Patients; Offers Clues to Predictive Biomarkers - Mayo Clinic News Network

    D., senior author of the study and co-director of the Biomarker Discovery Program in the Mayo Clinic Center for Individualized Medicine. ... situ [noninvasive ...

  9. Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome - Mayo Clinic

    Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in ... EXCEPTIONS: Non-melanotic skin cancer, ductal carcinoma in-situ, or carcinoma-in- ...

  10. PRe-emptive GEnome Discoveries Improving Care for Biobank VolunTeers (PREDICT) - Mayo Clinic

    EXCEPTIONS: Non-melanotic skin cancer or carcinoma-in-situ of the cervix. Prior genomic testing (i.e., Biobank 1,000 Whole Genome Sequencing Project, e ...